We identified 10 cancer-associated pathways whose enrichment was positively correlated with CD8+ T cell enrichment in HCC (Spearman correlation coefficient (ρ) > 0.3) (Figure 6A). The gene discussed is CD8A; the disease is hepatocellular carcinoma.